The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Taradin G.G.

Gorky Donetsk State Medical University

Ignatenko G.A.

Gorky Donetsk State Medical University

Rakitskaya I.V.

Gorky Donetsk State Medical University

Prikolota A.V.

Gorky Donetsk State Medical University

Bagriy V.A.

Donetsk City Central Clinical Hospital No. 1

Yefanov K.I.

Gorky Donetsk State Medical University

Dudnikova O.A.

Gorky Donetsk State Medical University

Clinical manifestation of apical hypertrophic cardiomyopathy by syncope in the elderly

Authors:

Taradin G.G., Ignatenko G.A., Rakitskaya I.V., Prikolota A.V., Bagriy V.A., Yefanov K.I., Dudnikova O.A.

More about the authors

Read: 701 times


To cite this article:

Taradin GG, Ignatenko GA, Rakitskaya IV, Prikolota AV, Bagriy VA, Yefanov KI, Dudnikova OA. Clinical manifestation of apical hypertrophic cardiomyopathy by syncope in the elderly. Russian Journal of Cardiology and Cardiovascular Surgery. 2025;18(2):237‑243. (In Russ.)
https://doi.org/10.17116/kardio202518021237

Recommended articles:

References:

  1. Maron BJ, Maron MS, Olivotto I. Hypertrophic cardiomyopathy. In: Braunwald’s Heart Disease: A Textbook of Cardiovascular Medicine, 11th ed, Eds: DP. Zipes, P. Libby, RO. Bonow, et al. Elsevier, 2019(78):3968-4007.
  2. Maron BJ, Desai MY, Nishimura RA, Spirito P, Rakowski H, Towbin JA, Rowin EJ, Maron MS, Sherrid MV. Diagnosis and evaluation of hypertrophic cardiomyopathy: JACC State-of-the-art review. J Am Coll Cardiol. 2022;79(4):372-389.  https://doi.org/10.1016/j.jacc.2021.12.002
  3. Massera D, Sherrid MV, Maron MS, Rowin EJ, Maron BJ. How common is hypertrophic cardiomyopathy… really?: Disease prevalence revisited 27 years after CARDIA. Int J Cardiol. 2023;382:64-67.  https://doi.org/10.1016/j.ijcard.2023.04.005
  4. Gabrusenko SA, Gudkova AYa, Koziolova NA et al. 2020 Clinical practice guidelines for hypertrophic cardiomyopathy. Russian Journal of Cardiology. 2021;26(5):4541. (In Russ.). https://doi.org/10.15829/1560-4071-2021-4541
  5. Ommen SR, Ho CY, Asif IM et al. 2024 AHA/ACC/AMSSM/HRS/PACES/SCMR Guideline for the management of hypertrophic cardiomyopathy: a report of the American Heart Association/American College of Cardiology Joint Committee on Clinical Practice Guidelines. Circulation. 2024;149(23):e1239-e1311. https://doi.org/10.1161/CIR.0000000000001250
  6. Parato VM, Antoncecchi V, Sozzi F, Marazia S, Zito A, Maiello M, Palmiero P; Italian Chapter of ISCU. Echocardiographic diagnosis of the different phenotypes of hypertrophic cardiomyopathy. Cardiovasc Ultrasound. 2016;14(1):30.  https://doi.org/10.1186/s12947-016-0072-5
  7. Ignatenko GA, Taradin GG, Kugler TE. Features of left ventricular hypertrophy and characteristics of phenotypic variants in patients with hypertrophic cardiomyopathy. Archive of Internal Medicine. 2023;13(4):282-293. (In Russ.). https://doi.org/10.20514/2226-6704-2023-13-4-282-293
  8. Taradin GG, Ignatenko GA, Kugler TE, Marushkin NS, Efanov KI. Apical hypertrophic cardiomyopathy. South Russian Journal of Therapeutic Practice. 2024;5(2):6-16. (In Russ.). https://doi.org/10.21886/2712-8156-2024-5-2-6-16
  9. Li J, Fang J, Liu Y, Wei X. Apical hypertrophic cardiomyopathy: pathophysiology, diagnosis and management. Clin Res Cardiol. 2024;113(5):680-693.  https://doi.org/10.1007/s00392-023-02328-8
  10. Maron MS, Rowin EJ, Maron BJ. Hypertrophic cardiomyopathy with left ventricular apical aneurysm: the newest high-risk phenotype. Eur Heart J Cardiovasc Imaging. 2020;21(12):1351-1352. https://doi.org/10.1093/ehjci/jeaa277
  11. Goncharova DYu, Bikbaeva GR, Tukhbatova AA, Mullova IS, Duplyakov DV. Apical hypertrophic cardiomyopathy as a mask of acute coronary syndrome: a case series. Russian Journal of Cardiology. 2021;26(5):4541. (In Russ.). https://doi.org/10.15829/1560-4071-2022-5262
  12. Kitaoka H, Doi Y, Casey SA, Hitomi N, Furuno T, Maron BJ. Comparison of prevalence of apical hypertrophic cardiomyopathy in Japan and the United States. Am J Cardiol. 2003;92(10):1183-1186. https://doi.org/10.1016/j.amjcard.2003.07.027
  13. Yang HS, Song JK, Song JM, Kang DH, Lee CW, Hong MK, Kim JJ, Park SW, Park SJ. Comparison of the clinical features of apical hypertrophic cardiomyopathy versus asymmetric septal hypertrophy in Korea. Korean J Intern Med. 2005;20(2):111-5.  https://doi.org/10.3904/kjim.2005.20.2.111
  14. Kubo T, Kitaoka H, Okawa M et al. Clinical profiles of hypertrophic cardiomyopathy with apical phenotype-comparison of pure-apical form and distal-dominant form. Circ J. 2009;73(12):2330-2336. https://doi.org/10.1253/circj.cj-09-0438
  15. Binder J, Attenhofer Jost CH, Klarich KW et al. Apical hypertrophic cardiomyopathy: prevalence and correlates of apical outpouching. J Am Soc Echocardiogr. 2011;24(7):775-781.  https://doi.org/10.1016/j.echo.2011.03.002
  16. Moon J, Shim CY, Ha JW et al. Clinical and echocardiographic predictors of outcomes in patients with apical hypertrophic cardiomyopathy. Am J Cardiol. 2011;108(11):1614-1619. https://doi.org/10.1016/j.amjcard.2011.07.024
  17. Yan L, Wang Z, Xu Z, Li Y, Tao Y, Fan C. Two hundred eight patients with apical hypertrophic cardiomyopathy in China: clinical feature, prognosis, and comparison of pure and mixed forms. Clin Cardiol. 2012;35(2):101-106.  https://doi.org/10.1002/clc.20995
  18. Kim SH, Kim SO, Han S et al. Long-term comparison of apical versus asymmetric hypertrophic cardiomyopathy. Int Heart J. 2013;54(4):207-211.  https://doi.org/10.1536/ihj.54.207
  19. Klarich KW, Attenhofer Jost CH, Binder J et al. Risk of death in long-term follow-up of patients with apical hypertrophic cardiomyopathy. Am J Cardiol. 2013;111(12):1784-1791. https://doi.org/10.1016/j.amjcard.2013.02.040
  20. Cai C, Duan FJ, Yang YJ et al. Comparison of the prevalence, clinical features, and long-term outcomes of midventricular hypertrophy vs apical phenotype in patients with hypertrophic cardiomyopathy. Can J Cardiol. 2014;30(4):441-447.  https://doi.org/10.1016/j.cjca.2013.10.005
  21. Kim EK, Lee SC, Hwang JW et al. Differences in apical and non-apical types of hypertrophic cardiomyopathy: a prospective analysis of clinical, echocardiographic, and cardiac magnetic resonance findings and outcome from 350 patients. Eur Heart J Cardiovasc Imaging. 2016;17(6):678-86.  https://doi.org/10.1093/ehjci/jev192
  22. Neubauer S, Kolm P, Ho CY et al. HCMR Investigators. Distinct Subgroups in Hypertrophic Cardiomyopathy in the NHLBI HCM Registry. J Am Coll Cardiol. 2019;74(19):2333-2345. https://doi.org/10.1016/j.jacc.2019.08.1057
  23. Yin Y, Hu W, Zhang L, Wu D, Yang C, Ye X. Clinical, echocardiographic and cardiac MRI predictors of outcomes in patients with apical hypertrophic cardiomyopathy. Int J Cardiovasc Imaging. 2022;38(3):643-651.  https://doi.org/10.1007/s10554-021-02430-w
  24. Hughes RK, Knott KD, Malcolmson J, Augusto JB, Mohiddin SA, Kellman P, Moon JC, Captur G. Apical hypertrophic cardiomyopathy: the variant less known. J Am Heart Assoc. 2020;9(5):e015294. https://doi.org/10.1161/JAHA.119.015294
  25. Maron BJ. Clinical course and management of hypertrophic cardiomyopathy. N Engl J Med. 2018;379(7):655-668.  https://doi.org/10.1056/NEJMra1710575
  26. Tao Y, Xu J, Bako SY, Yao X, Yang D. Usefulness of ECG to differentiate apical hypertrophic cardiomyopathy from non-ST elevation acute coronary syndrome. BMC Cardiovasc Disord. 2020;20(1):306.  https://doi.org/10.1186/s12872-020-01592-0
  27. Caiati C, Stanca A, Lepera ME. Case report: diagnosis of apical hypertrophic cardiomyopathy that escaped clinical and echocardiographic investigations for twenty years: reasons and clinical implications. Front Cardiovasc Med. 2023;10:1157599. https://doi.org/10.3389/fcvm.2023.1157599
  28. Yusuf SW, Bathina JD, Banchs J, Mouhayar EN, Daher IN. Apical hypertrophic cardiomyopathy. World J Cardiol. 2011;3(7):256-259.  https://doi.org/10.4330/wjc.v3.i7.256
  29. Marian AJ, Braunwald E. Hypertrophic cardiomyopathy: genetics, pathogenesis, clinical manifestations, diagnosis, and therapy. Circ Res. 2017;121(7):749-770.  https://doi.org/10.1161/CIRCRESAHA.117.311059
  30. Mascia G, Crotti L, Groppelli A et al. Syncope in hypertrophic cardiomyopathy (part I): an updated systematic review and meta-analysis. Int J Cardiol. 2022;357:88-94.  https://doi.org/10.1016/j.ijcard.2022.03.028
  31. Arbelo E, Protonotarios A, Gimeno JR et al. ESC Scientific Document Group. 2023 ESC Guidelines for the management of cardiomyopathies. Eur Heart J. 2023;44(37):3503-3626. https://doi.org/10.1093/eurheartj/ehad194
  32. Brignole M, Cecchi F, Anastasakis A et al. Syncope in hypertrophic cardiomyopathy (part II): an expert consensus statement on the diagnosis and management. Int J Cardiol. 2023;370:330-337.  https://doi.org/10.1016/j.ijcard.2022.10.153
  33. Baxi AJ, Restrepo CS, Vargas D, Marmol-Velez A, Ocazionez D, Murillo H. Hypertrophic cardiomyopathy from A to Z: genetics, pathophysiology, imaging, and management. Radiographics. 2016;36(2):335-354.  https://doi.org/10.1148/rg.2016150137
  34. Yamaguchi H, Ishimura T, Nishiyama S et al. Hypertrophic nonobstructive cardiomyopathy with giant negative T waves (apical hypertrophy): ventriculographic and echocardiographic features in 30 patients. Am J Cardiol. 1979;44(3):401-412.  https://doi.org/10.1016/0002-9149(79)90388-6
  35. Hughes RK, Thornton GD, Malcolmson JW et al. Accurate diagnosis of apical hypertrophic cardiomyopathy using explainable advanced electrocardiogram analysis. Europace. 2024 Mar 30;26(4):euae093. https://doi.org/10.1093/europace/euae093
  36. Hughes RK, Shiwani H, Rosmini S et al. Improved diagnostic criteria for apical hypertrophic cardiomyopathy. JACC Cardiovasc Imaging. 2024;17(5):501-512.  https://doi.org/10.1016/j.jcmg.2023.07.012
  37. Eriksson MJ, Sonnenberg B, Woo A, Rakowski P, Parker TG, Wigle ED, Rakowski H. Long-term outcome in patients with apical hypertrophic cardiomyopathy. J Am Coll Cardiol. 2002;39(4):638-45.  https://doi.org/10.1016/s0735-1097(01)01778-8
  38. Huang W, Guan L, Liu L, Mu Y. Apical hypertrophic cardiomyopathy with apical endomyocardial fibrosis and calcification: two case reports. Medicine (Baltimore) 2019;98(27):e16183. https://doi.org/10.1097/MD.0000000000016183
  39. Afanasyev A, Bogachev-Prokophiev A, Zheleznev S et al. Transapical approach to septal myectomy for hypertrophic cardiomyopathy. Life (Basel). 2024;14(1):125.  https://doi.org/10.3390/life14010125

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.